Women’s Health Market Size, Share & Trends Analysis Report By Application (Hormonal Infertility, Endometriosis & Uterine Fibroids, Contraceptives, PCOS), By Age, By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 48 Business Hours
Women’s Health Market Growth & Trends
The global women’s health market size is expected to reach USD 58.24 billion by 2030, registering a CAGR of 4.8% over the forecast period, according to a new report by Grand View Research, Inc. The introduction of innovative novel products and the presence of a strong pipeline of women’s health products are prime factors driving the market growth. For instance, in May 2021, the Food & Drug Administration approved Myfembree, developed by Pfizer Inc. in collaboration with Myovant Sciences, for uterine fibroids associated with heavy menstrual bleeding. An increase in the incidence of endometriosis and a rise in support from non-profit organizations are expected to fuel the market growth over the forecast period.
For instance, the Bill & Melinda Gates Foundation pledged USD 280 million every year from 2021 to 2030 for the development of new contraceptive technologies and to support family planning initiatives. According to the WHO report 2021, globally, around 10% (190 million) of reproductive-age girls and women are affected by endometriosis. It is a chronic disease related to severe pain during periods, bowel movements and/or urination, abdominal bloating, nausea, fatigue, etc. The COVID-19 pandemic had a negative impact on the market. Strict measures undertaken by governments to control the spread of the SARS-CoV-2, such as social distancing and community-wide lockdowns, have had a detrimental impact on treatment facilities & gynecological clinics.
For instance, in low- and middle-income countries there has been a decline in the usage of long- and short-acting reversible contraceptives. Strategic initiatives undertaken by key players, such as collaborations, agreements, and partnerships, for the development and commercialization of products are anticipated to drive market growth. For instance, in October 2021, Richter and Hikma signed an exclusive licensing agreement to commercialize denosumab, comprising biosimilar of Xgeva and Prolia in the U.S. Moreover, the growing competition from generic drugs increases the pricing pressure after patent expiration, which is anticipated to impede market growth.
For instance, after the patent expiry, the revenue of Forteo declined by 23% between 2020 and 2021. North America dominated the global market in 2021 owing to favorable reimbursement policies, the presence of key market players, supportive government regulations, approval & commercialization of products, and high usage of contraceptives among women. The Asia Pacific region is expected to grow at the fastest CAGR during the forecast period due to rising government spending on women’s health. For instance, the Australian Government announced an investment of USD 333 million to support health services and support.
Women’s Health Market Report Highlights
Women’s Health Market Growth & Trends
The global women’s health market size is expected to reach USD 58.24 billion by 2030, registering a CAGR of 4.8% over the forecast period, according to a new report by Grand View Research, Inc. The introduction of innovative novel products and the presence of a strong pipeline of women’s health products are prime factors driving the market growth. For instance, in May 2021, the Food & Drug Administration approved Myfembree, developed by Pfizer Inc. in collaboration with Myovant Sciences, for uterine fibroids associated with heavy menstrual bleeding. An increase in the incidence of endometriosis and a rise in support from non-profit organizations are expected to fuel the market growth over the forecast period.
For instance, the Bill & Melinda Gates Foundation pledged USD 280 million every year from 2021 to 2030 for the development of new contraceptive technologies and to support family planning initiatives. According to the WHO report 2021, globally, around 10% (190 million) of reproductive-age girls and women are affected by endometriosis. It is a chronic disease related to severe pain during periods, bowel movements and/or urination, abdominal bloating, nausea, fatigue, etc. The COVID-19 pandemic had a negative impact on the market. Strict measures undertaken by governments to control the spread of the SARS-CoV-2, such as social distancing and community-wide lockdowns, have had a detrimental impact on treatment facilities & gynecological clinics.
For instance, in low- and middle-income countries there has been a decline in the usage of long- and short-acting reversible contraceptives. Strategic initiatives undertaken by key players, such as collaborations, agreements, and partnerships, for the development and commercialization of products are anticipated to drive market growth. For instance, in October 2021, Richter and Hikma signed an exclusive licensing agreement to commercialize denosumab, comprising biosimilar of Xgeva and Prolia in the U.S. Moreover, the growing competition from generic drugs increases the pricing pressure after patent expiration, which is anticipated to impede market growth.
For instance, after the patent expiry, the revenue of Forteo declined by 23% between 2020 and 2021. North America dominated the global market in 2021 owing to favorable reimbursement policies, the presence of key market players, supportive government regulations, approval & commercialization of products, and high usage of contraceptives among women. The Asia Pacific region is expected to grow at the fastest CAGR during the forecast period due to rising government spending on women’s health. For instance, the Australian Government announced an investment of USD 333 million to support health services and support.
Women’s Health Market Report Highlights
- The contraceptives application segment accounted for the largest share of the market in 2021 due to supportive reimbursement policies by private & government organizations
- The University of California Bixby Center released a reimbursement guide to help health providers offer women a full range of contraceptives
- The endometriosis segment is expected to witness significant growth over the forecast period due to the launch of products, such as Relugoliz and the impending launch of Linzagolix for the treatment of women with uterine fibroids
- Based on age, the 50 years and above segment is expected to witness the fastest CAGRfrom 2022 to 2030 owing to the high risk of developing endometriosis and menopause
- According to the International Menopause Society, globally, women aged between 45 and 55 years typically experience menopause, with the average age of onset at 51.5 years
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation
1.2 Research Methodology
1.3 Research Assumptions
1.3.1 Estimates and Forecast Timeline
1.4 Research Methodology
1.5 Information Procurement
1.5.1 Purchased Database
1.5.2 GVR’s Internal Database
1.5.3 Secondary Sources
1.5.4 Primary Research
1.5.5 Details of Primary Research
1.6 Information or Data Analysis
1.6.1 Data Analysis Models
1.7 Market Formulation & Validation
1.8 Model Details
1.8.1 Commodity Flow Analysis
1.8.1.1 Approach 1: Commodity flow approach
1.8.1.2 Approach 2: Country wise market estimation using bottom up approach
1.9 Global Market: CAGR Calculation
1.10 List of Secondary Sources
1.11 List of Primary Sources
1.12 Objectives
1.12.1 Objective 1:
1.12.2 Objective 2:
1.13 List of Tables
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Summary
CHAPTER 3 WOMEN’S HEALTH MARKET VARIABLES, TRENDS & SCOPE
3.1 Women’s Health Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Regulatory and Reimbursement Framework
3.4 Market Dynamics
3.4.1 Market driver analysis
3.4.1.1 Rising incidence of target diseases
3.4.1.2 Child or early marriages
3.4.1.3 Increasing initiatives by the government and various organizations
3.4.1.4 Rising publicly funded family planning services
3.4.2 Market restraint analysis
3.4.2.1 Patent expiry of major drugs
3.4.2.2 Lawsuits related to products
3.4.2.2 Adverse effects associated with use of contraceptive drugs and devices
3.5 Women’s Health Market Analysis Tools
3.5.1 Porter’s Five Forces Analysis
3.5.2 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
3.6 Major Deals and Strategic Alliances
3.7 Women’s Health Market Analysis Tools
3.8 Market size estimates for key products (global level estimates and forecasts)
3.8.1. Evista
3.8.1.1. Evista Market, 2018 to 2030 (USD Million)
3.8.2. Xgeva
3.8.2.1. Xgeva Market, 2018 to 2030 (USD Million)
3.8.3. Prolia
3.8.3.1. Prolia Market, 2018 to 2030 (USD Million)
3.8.4. Mirena
3.8.4.1. Mirena Market, 2018 to 2030 (USD Million)
3.8.5. Zometa
3.8.5.1. Zometa Market, 2018 to 2030 (USD Million)
3.8.6. Reclast/Aclasta
3.8.6.1. Reclast/Aclasta Market, 2018 to 2030 (USD Million)
3.8.7. Minastrin 24FE
3.8.7.1. Minastrin 24FE Market, 2018 to 2030 (USD Million)
3.8.8. NuvaRing
3.8.8.1. NuvaRing Market, 2018 to 2030 (USD Million)
3.8.9. Forteo
3.8.9.1. Forteo Market, 2018 to 2030 (USD Million)
3.8.10. Premarin
3.8.10.1. Premarin Market, 2018 to 2030 (USD Million)
3.8.11. Actonel
3.8.11.1. Actonel Market, 2018 to 2030 (USD Million)
3.8.12. Ortho-Tri-Cy Lo
3.8.12.1. Ortho-Tri-Cy Lo 28 Market, 2018 to 2030 (USD Million)
CHAPTER 4 WOMEN’S HEALTH MARKET - COMPETITIVE ANALYSIS
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.1.1 Company/Competition Categorization (Key innovators, Market leaders, Expansion)
4.1.2 Major deals and strategic alliances
4.2 Vendor Landscape
4.2.1 List of key distributors and channel partners
4.2.2 Key company market share analysis, 2021
4.3 Public Companies
4.3.1 Company market position analysis
4.3.2 Competitive Dashboard Analysis
4.4 Private Companies
4.4.1 List of key emerging companies /technology disruptors/innovators
4.4.2 Regional network map
CHAPTER 5 APPLICATION BUSINESS ANALYSIS
5.1 Women’s Health Market: Application Movement Analysis
5.2 Postmenopausal Osteoporosis
5.2.1 Postmenopausal Osteoporosis market, 2018 - 2030 (USD Million)
5.3 Hormonal Infertility
5.3.1 Hormonal infertility market, 2018 - 2030 (USD Million)
5.4 Endometriosis and Uterine Fibroids
5.4.1 Endometriosis and Uterine Fibroids market, 2018 - 2030 (USD Million)
5.5 Contraceptives
5.5.1 Contraceptives market, 2018 - 2030 (USD Million)
5.6 Menopause
5.6.1 Menopause market, 2018 - 2030 (USD Million)
5.7 Polycystic Ovary Syndrome (PCOS)
5.7.1 PCOS market, 2018 - 2030 (USD Million)
CHAPTER 6 AGE SEGMENT ANALYSIS
6.1 Women’s Health Market: Age Movement Analysis
6.2 50 years and above
6.2.1 50 years and above market, 2018 - 2030 (USD Million)
6.2.1.2 Postmenopausal Osteoporosis market, 50 years and above, 2018 - 2030 (USD Million)
6.2.1.3 Endometriosis and Uterine Fibroids market, 50 years and above, 2018 - 2030 (USD Million)
6.2.1.4 Menopause market, 50 years and above, 2018 - 2030 (USD Million)
6.2.1.5 Others market, 50 years and above, 2018 - 2030 (USD Million)
6.3 Others
6.3.1 Others market, 2018 - 2030 (USD Million)
CHAPTER 7 REGIONAL BUSINESS ANALYSIS
7.1 Women’s Health Market: Regional Movement Analysis
7.1.1 North America
7.1.1.1 North America market estimates and forecast, 2018 - 2030, USD Million
7.1.1.2 U.S.
7.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030, USD Million
7.1.1.3 Canada
7.1.1.3.1 Canada market estimates and forecast, 2018 - 2030, USD Million
7.1.2 Europe
7.1.2.1 Europe market estimates and forecast, 2018 - 2030, USD Million
7.1.2.2 U.K.
7.1.2.2.1 U.K. market estimates and forecast, 2018 - 2030, USD Million
7.1.2.3 Germany
7.1.2.3.1 Germany market estimates and forecast, 2018 - 2030, USD Million
7.1.2.4 France
7.1.2.4.1 France market estimates and forecast, 2018 - 2030, USD Million
7.1.2.5 Spain
7.1.2.5.1 Spain market estimates and forecast, 2018 - 2030, USD Million
7.1.2.6 Italy
7.1.2.6.1 Italy market estimates and forecast, 2018 - 2030, USD Million
7.1.3 Asia Pacific
7.1.3.1 Asia Pacific market estimates and forecast, 2018 - 2030, USD Million
7.1.3.2 Japan
7.1.3.2.1 Japan market estimates and forecast, 2018 - 2030, USD Million
7.1.3.3 China
7.1.3.3.1 China market estimates and forecast, 2018 - 2030, USD Million
7.1.3.4 India
7.1.3.4.1 India market estimates and forecast, 2018 - 2030, USD Million
7.1.3.5 Australia
7.1.3.5.1 Australia market estimates and forecast, 2018 - 2030, USD Million
7.1.3.6 South Korea
7.1.3.6.1 South Korea market estimates and forecast, 2018 - 2030, USD Million
7.1.4 Latin America
7.1.4.1 Latin America market estimates and forecast, 2018 - 2030, USD Million
7.1.4.2 Brazil
7.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030, USD Million
7.1.4.3 Mexico
7.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030, USD Million
7.1.5 Middle East & Africa
7.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030, USD Million
7.1.5.2 South Africa
7.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030, USD Million
CHAPTER 8 COMPANY PROFILES
8.1 Market Participation Categorization
8.2 Company Profiles
8.2.1 AbbVie, Inc.
8.2.2 Bayer AG.
8.2.3 Merck & Co., Inc.
8.2.4 Pfizer, Inc.
8.2.5 Teva Pharmaceutical Industries Ltd.
8.2.6 Agile Therapeutics
8.2.7 Amgen, Inc.
8.2.8 Apothecus Pharmaceutical Corp.
8.2.9 Blairex Laboratories, Inc.
8.2.10 Ferring B.V.
1.1 Market Segmentation
1.2 Research Methodology
1.3 Research Assumptions
1.3.1 Estimates and Forecast Timeline
1.4 Research Methodology
1.5 Information Procurement
1.5.1 Purchased Database
1.5.2 GVR’s Internal Database
1.5.3 Secondary Sources
1.5.4 Primary Research
1.5.5 Details of Primary Research
1.6 Information or Data Analysis
1.6.1 Data Analysis Models
1.7 Market Formulation & Validation
1.8 Model Details
1.8.1 Commodity Flow Analysis
1.8.1.1 Approach 1: Commodity flow approach
1.8.1.2 Approach 2: Country wise market estimation using bottom up approach
1.9 Global Market: CAGR Calculation
1.10 List of Secondary Sources
1.11 List of Primary Sources
1.12 Objectives
1.12.1 Objective 1:
1.12.2 Objective 2:
1.13 List of Tables
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Summary
CHAPTER 3 WOMEN’S HEALTH MARKET VARIABLES, TRENDS & SCOPE
3.1 Women’s Health Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Regulatory and Reimbursement Framework
3.4 Market Dynamics
3.4.1 Market driver analysis
3.4.1.1 Rising incidence of target diseases
3.4.1.2 Child or early marriages
3.4.1.3 Increasing initiatives by the government and various organizations
3.4.1.4 Rising publicly funded family planning services
3.4.2 Market restraint analysis
3.4.2.1 Patent expiry of major drugs
3.4.2.2 Lawsuits related to products
3.4.2.2 Adverse effects associated with use of contraceptive drugs and devices
3.5 Women’s Health Market Analysis Tools
3.5.1 Porter’s Five Forces Analysis
3.5.2 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
3.6 Major Deals and Strategic Alliances
3.7 Women’s Health Market Analysis Tools
3.8 Market size estimates for key products (global level estimates and forecasts)
3.8.1. Evista
3.8.1.1. Evista Market, 2018 to 2030 (USD Million)
3.8.2. Xgeva
3.8.2.1. Xgeva Market, 2018 to 2030 (USD Million)
3.8.3. Prolia
3.8.3.1. Prolia Market, 2018 to 2030 (USD Million)
3.8.4. Mirena
3.8.4.1. Mirena Market, 2018 to 2030 (USD Million)
3.8.5. Zometa
3.8.5.1. Zometa Market, 2018 to 2030 (USD Million)
3.8.6. Reclast/Aclasta
3.8.6.1. Reclast/Aclasta Market, 2018 to 2030 (USD Million)
3.8.7. Minastrin 24FE
3.8.7.1. Minastrin 24FE Market, 2018 to 2030 (USD Million)
3.8.8. NuvaRing
3.8.8.1. NuvaRing Market, 2018 to 2030 (USD Million)
3.8.9. Forteo
3.8.9.1. Forteo Market, 2018 to 2030 (USD Million)
3.8.10. Premarin
3.8.10.1. Premarin Market, 2018 to 2030 (USD Million)
3.8.11. Actonel
3.8.11.1. Actonel Market, 2018 to 2030 (USD Million)
3.8.12. Ortho-Tri-Cy Lo
3.8.12.1. Ortho-Tri-Cy Lo 28 Market, 2018 to 2030 (USD Million)
CHAPTER 4 WOMEN’S HEALTH MARKET - COMPETITIVE ANALYSIS
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.1.1 Company/Competition Categorization (Key innovators, Market leaders, Expansion)
4.1.2 Major deals and strategic alliances
4.2 Vendor Landscape
4.2.1 List of key distributors and channel partners
4.2.2 Key company market share analysis, 2021
4.3 Public Companies
4.3.1 Company market position analysis
4.3.2 Competitive Dashboard Analysis
4.4 Private Companies
4.4.1 List of key emerging companies /technology disruptors/innovators
4.4.2 Regional network map
CHAPTER 5 APPLICATION BUSINESS ANALYSIS
5.1 Women’s Health Market: Application Movement Analysis
5.2 Postmenopausal Osteoporosis
5.2.1 Postmenopausal Osteoporosis market, 2018 - 2030 (USD Million)
5.3 Hormonal Infertility
5.3.1 Hormonal infertility market, 2018 - 2030 (USD Million)
5.4 Endometriosis and Uterine Fibroids
5.4.1 Endometriosis and Uterine Fibroids market, 2018 - 2030 (USD Million)
5.5 Contraceptives
5.5.1 Contraceptives market, 2018 - 2030 (USD Million)
5.6 Menopause
5.6.1 Menopause market, 2018 - 2030 (USD Million)
5.7 Polycystic Ovary Syndrome (PCOS)
5.7.1 PCOS market, 2018 - 2030 (USD Million)
CHAPTER 6 AGE SEGMENT ANALYSIS
6.1 Women’s Health Market: Age Movement Analysis
6.2 50 years and above
6.2.1 50 years and above market, 2018 - 2030 (USD Million)
6.2.1.2 Postmenopausal Osteoporosis market, 50 years and above, 2018 - 2030 (USD Million)
6.2.1.3 Endometriosis and Uterine Fibroids market, 50 years and above, 2018 - 2030 (USD Million)
6.2.1.4 Menopause market, 50 years and above, 2018 - 2030 (USD Million)
6.2.1.5 Others market, 50 years and above, 2018 - 2030 (USD Million)
6.3 Others
6.3.1 Others market, 2018 - 2030 (USD Million)
CHAPTER 7 REGIONAL BUSINESS ANALYSIS
7.1 Women’s Health Market: Regional Movement Analysis
7.1.1 North America
7.1.1.1 North America market estimates and forecast, 2018 - 2030, USD Million
7.1.1.2 U.S.
7.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030, USD Million
7.1.1.3 Canada
7.1.1.3.1 Canada market estimates and forecast, 2018 - 2030, USD Million
7.1.2 Europe
7.1.2.1 Europe market estimates and forecast, 2018 - 2030, USD Million
7.1.2.2 U.K.
7.1.2.2.1 U.K. market estimates and forecast, 2018 - 2030, USD Million
7.1.2.3 Germany
7.1.2.3.1 Germany market estimates and forecast, 2018 - 2030, USD Million
7.1.2.4 France
7.1.2.4.1 France market estimates and forecast, 2018 - 2030, USD Million
7.1.2.5 Spain
7.1.2.5.1 Spain market estimates and forecast, 2018 - 2030, USD Million
7.1.2.6 Italy
7.1.2.6.1 Italy market estimates and forecast, 2018 - 2030, USD Million
7.1.3 Asia Pacific
7.1.3.1 Asia Pacific market estimates and forecast, 2018 - 2030, USD Million
7.1.3.2 Japan
7.1.3.2.1 Japan market estimates and forecast, 2018 - 2030, USD Million
7.1.3.3 China
7.1.3.3.1 China market estimates and forecast, 2018 - 2030, USD Million
7.1.3.4 India
7.1.3.4.1 India market estimates and forecast, 2018 - 2030, USD Million
7.1.3.5 Australia
7.1.3.5.1 Australia market estimates and forecast, 2018 - 2030, USD Million
7.1.3.6 South Korea
7.1.3.6.1 South Korea market estimates and forecast, 2018 - 2030, USD Million
7.1.4 Latin America
7.1.4.1 Latin America market estimates and forecast, 2018 - 2030, USD Million
7.1.4.2 Brazil
7.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030, USD Million
7.1.4.3 Mexico
7.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030, USD Million
7.1.5 Middle East & Africa
7.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030, USD Million
7.1.5.2 South Africa
7.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030, USD Million
CHAPTER 8 COMPANY PROFILES
8.1 Market Participation Categorization
8.2 Company Profiles
8.2.1 AbbVie, Inc.
8.2.2 Bayer AG.
8.2.3 Merck & Co., Inc.
8.2.4 Pfizer, Inc.
8.2.5 Teva Pharmaceutical Industries Ltd.
8.2.6 Agile Therapeutics
8.2.7 Amgen, Inc.
8.2.8 Apothecus Pharmaceutical Corp.
8.2.9 Blairex Laboratories, Inc.
8.2.10 Ferring B.V.
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 North America Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 4 North America Women’s Health market estimates and forecasts, by age, 2018 - 2030
Table 5 U.S. Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 6 U.S. Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 7 Canada Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 8 Canada Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 9 Europe Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 10 Europe Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 11 U.K. Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 12 U.K. Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 13 Germany Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 14 Germany Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 15 France Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 16 France Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 17 Italy Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 18 Italy Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 19 Spain Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 20 Spain Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 21 Asia Pacific Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 22 Asia Pacific Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 23 Japan Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 24 Japan Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 25 China Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 26 China Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 27 India Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 28 India Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 29 Australia Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 30 Australia Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 31 South Korea Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 32 South Korea Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 33 Latin America Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 34 Latin America Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 35 Brazil Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 36 Brazil Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 37 Mexico Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 38 Mexico Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 41 MEA Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 42 MEA Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 43 South Africa Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 44 South Africa Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 49 List of key distributors
Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 North America Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 4 North America Women’s Health market estimates and forecasts, by age, 2018 - 2030
Table 5 U.S. Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 6 U.S. Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 7 Canada Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 8 Canada Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 9 Europe Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 10 Europe Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 11 U.K. Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 12 U.K. Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 13 Germany Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 14 Germany Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 15 France Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 16 France Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 17 Italy Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 18 Italy Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 19 Spain Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 20 Spain Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 21 Asia Pacific Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 22 Asia Pacific Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 23 Japan Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 24 Japan Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 25 China Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 26 China Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 27 India Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 28 India Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 29 Australia Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 30 Australia Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 31 South Korea Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 32 South Korea Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 33 Latin America Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 34 Latin America Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 35 Brazil Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 36 Brazil Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 37 Mexico Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 38 Mexico Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 41 MEA Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 42 MEA Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 43 South Africa Women’s Health market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 44 South Africa Women’s Health market estimates and forecasts, by age, 2018 - 2030 (USD Million)
Table 49 List of key distributors
LIST OF FIGURES
Fig. 1 Women’s health market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Women’s health market snapshot
Fig. 10 Market trends & outlook
Fig. 11 Penetration & growth prospect mapping
Fig. 12 Consumer Behavior Analysis
Fig. 13 Market driver relevance analysis (Current & future impact)
Fig. 14 Market restraint relevance analysis (Current & future impact)
Fig. 15 Porter’s five forces analysis
Fig. 16 Evista market, 2018 - 2030 (USD Million)
Fig. 17 Xgeva market, 2018 - 2030 (USD Million)
Fig. 18 Prolia market, 2018 - 2030 (USD Million)
Fig. 19 Mirena market, 2018 - 2030 (USD Million)
Fig. 20 Zometa market, 2018 - 2030 (USD Million)
Fig. 21 Reclast/Aclasta market, 2018 - 2030 (USD Million)
Fig. 22 Minastrin 24FE market, 2018 - 2030 (USD Million)
Fig. 23 NuvaRing market, 2018 - 2030 (USD Million)
Fig. 24 Forteo market, 2018 - 2030 (USD Million)
Fig. 25 Premarin market, 2018 - 2030 (USD Million)
Fig. 26 Actonel market, 2018 - 2030 (USD Million)
Fig. 27 Ortho-Tri-Cy Lo 28 market, 2018 - 2030 (USD Million)
Fig. 28 Women’s health application market share analysis, 2021 & 2030
Fig. 29 Women’s health application market: Segment dashboard
Fig. 30 Postmenopausal osteoporosis market, 2018 - 2030 (USD Million)
Fig. 31 Hormonal infertility market, 2018 - 2030 (USD Million)
Fig. 32 Endometriosis & Uterine Fibroids market, 2018 - 2030 (USD Million)
Fig. 33 Contraceptives market, 2018 - 2030 (USD Million)
Fig. 34 Menopause market, 2018 - 2030 (USD Million)
Fig. 35 PCOS market, 2018 - 2030 (USD Million)
Fig. 36 Women’s health age market share analysis, 2021 & 2030
Fig. 37 Women’s health Age market: Segment dashboard
Fig. 38 50 years and above market, 2018 - 2030 (USD Million)
Fig. 39 Postmenopausal Osteoporosis market, 50 years and above, 2018 - 2030 (USD Million)
Fig. 40 Endometriosis market, 50 years and above, 2018 - 2030 (USD Million)
Fig. 41 Menopause market, 50 years and above, 2018 - 2030 (USD Million)
Fig. 42 Others market, 50 years and above, 2018 - 2030 (USD Million)
Fig. 43 Others market, 2018 - 2030 (USD Million)
Fig. 44 Women’s health market: Regional outlook and key takeaways
Fig. 45 Women’s health market: Regional movement analysis
Fig. 46 North America
Fig. 47 North America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 U.S.
Fig. 49 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Canada
Fig. 51 Canada market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Europe
Fig. 53 Europe market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 U.K.
Fig. 55 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Germany
Fig. 57 Germany market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Italy
Fig. 59 Italy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Spain
Fig. 61 Spain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 France
Fig. 63 France market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Asia Pacific
Fig. 65 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 Japan
Fig. 67 Japan market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 China
Fig. 69 China market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 India
Fig. 71 India market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Australia
Fig. 73 Australia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 South Korea
Fig. 75 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Latin America
Fig. 77 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Brazil
Fig. 79 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Mexico
Fig. 81 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 82 Middle East & Africa
Fig. 83 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 84 South Africa
FIG.85 Company market share analysis
FIG.86 Company market position analysis (Revenue. US$ mn)
FIG.87 Company market position analysis (Profit Margin)
Fig. 88 Competitive dashboard analysis
Fig. 89 Regional Network Map
Fig. 1 Women’s health market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Women’s health market snapshot
Fig. 10 Market trends & outlook
Fig. 11 Penetration & growth prospect mapping
Fig. 12 Consumer Behavior Analysis
Fig. 13 Market driver relevance analysis (Current & future impact)
Fig. 14 Market restraint relevance analysis (Current & future impact)
Fig. 15 Porter’s five forces analysis
Fig. 16 Evista market, 2018 - 2030 (USD Million)
Fig. 17 Xgeva market, 2018 - 2030 (USD Million)
Fig. 18 Prolia market, 2018 - 2030 (USD Million)
Fig. 19 Mirena market, 2018 - 2030 (USD Million)
Fig. 20 Zometa market, 2018 - 2030 (USD Million)
Fig. 21 Reclast/Aclasta market, 2018 - 2030 (USD Million)
Fig. 22 Minastrin 24FE market, 2018 - 2030 (USD Million)
Fig. 23 NuvaRing market, 2018 - 2030 (USD Million)
Fig. 24 Forteo market, 2018 - 2030 (USD Million)
Fig. 25 Premarin market, 2018 - 2030 (USD Million)
Fig. 26 Actonel market, 2018 - 2030 (USD Million)
Fig. 27 Ortho-Tri-Cy Lo 28 market, 2018 - 2030 (USD Million)
Fig. 28 Women’s health application market share analysis, 2021 & 2030
Fig. 29 Women’s health application market: Segment dashboard
Fig. 30 Postmenopausal osteoporosis market, 2018 - 2030 (USD Million)
Fig. 31 Hormonal infertility market, 2018 - 2030 (USD Million)
Fig. 32 Endometriosis & Uterine Fibroids market, 2018 - 2030 (USD Million)
Fig. 33 Contraceptives market, 2018 - 2030 (USD Million)
Fig. 34 Menopause market, 2018 - 2030 (USD Million)
Fig. 35 PCOS market, 2018 - 2030 (USD Million)
Fig. 36 Women’s health age market share analysis, 2021 & 2030
Fig. 37 Women’s health Age market: Segment dashboard
Fig. 38 50 years and above market, 2018 - 2030 (USD Million)
Fig. 39 Postmenopausal Osteoporosis market, 50 years and above, 2018 - 2030 (USD Million)
Fig. 40 Endometriosis market, 50 years and above, 2018 - 2030 (USD Million)
Fig. 41 Menopause market, 50 years and above, 2018 - 2030 (USD Million)
Fig. 42 Others market, 50 years and above, 2018 - 2030 (USD Million)
Fig. 43 Others market, 2018 - 2030 (USD Million)
Fig. 44 Women’s health market: Regional outlook and key takeaways
Fig. 45 Women’s health market: Regional movement analysis
Fig. 46 North America
Fig. 47 North America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 U.S.
Fig. 49 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Canada
Fig. 51 Canada market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Europe
Fig. 53 Europe market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 U.K.
Fig. 55 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Germany
Fig. 57 Germany market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Italy
Fig. 59 Italy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Spain
Fig. 61 Spain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 France
Fig. 63 France market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Asia Pacific
Fig. 65 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 Japan
Fig. 67 Japan market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 China
Fig. 69 China market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 India
Fig. 71 India market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Australia
Fig. 73 Australia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 South Korea
Fig. 75 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Latin America
Fig. 77 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Brazil
Fig. 79 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Mexico
Fig. 81 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 82 Middle East & Africa
Fig. 83 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 84 South Africa
FIG.85 Company market share analysis
FIG.86 Company market position analysis (Revenue. US$ mn)
FIG.87 Company market position analysis (Profit Margin)
Fig. 88 Competitive dashboard analysis
Fig. 89 Regional Network Map
